BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Diagnosis
1854 results:

  • 1. The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy.
    Lokeshwar SD; Ali A; Weiss TR; Reynolds J; Shuch BM; Ferencz T; Kyriakides TC; Mehal WZ; Brito J; Renzulli J; Leapman MS
    BMC Urol; 2024 May; 24(1):102. PubMed ID: 38702664
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Plant-Based Diets and Disease Progression in Men With prostate cancer.
    Liu VN; Van Blarigan EL; Zhang L; Graff RE; Loeb S; Langlais CS; Cowan JE; Carroll PR; Chan JM; Kenfield SA
    JAMA Netw Open; 2024 May; 7(5):e249053. PubMed ID: 38691361
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [prostate cancer - a disease in transformation].
    Bratt O
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38661575
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Skin Changes in Suspected Lyme Disease.
    Vržogić P; Perica A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Patterns of Care for Medicare Beneficiaries With Metastatic prostate cancer.
    Filson CP; Richards TB; Ekwueme DU; Howard DH
    Urol Pract; 2024 May; 11(3):489-497. PubMed ID: 38640419
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [A single center study:An analysis of the safety and validity of delaying repeated biopsy for patients with atypical small acinar proliferation].
    Ji WT; Liu DC; Cui WL; Hu Y; Wang Y; Tan JF
    Zhonghua Nan Ke Xue; 2023 May; 29(5):414-419. PubMed ID: 38602757
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. prostate-Specific Antigen Screening and 15-Year prostate cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
    Martin RM; Turner EL; Young GJ; Metcalfe C; Walsh EI; Lane JA; Sterne JAC; Noble S; Holding P; Ben-Shlomo Y; Williams NJ; Pashayan N; Bui MN; Albertsen PC; Seibert TM; Zietman AL; Oxley J; Adolfsson J; Mason MD; Davey Smith G; Neal DE; Hamdy FC; Donovan JL;
    JAMA; 2024 May; 331(17):1460-1470. PubMed ID: 38581198
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Assessment of the accuracy of biparametric MRI/TRUS fusion-guided biopsy for index tumor evaluation using postoperative pathology specimens.
    Shimizu R; Morizane S; Yamamoto A; Yamane H; Nishikawa R; Kimura Y; Yamaguchi N; Hikita K; Honda M; Takenaka A
    BMC Urol; 2024 Apr; 24(1):79. PubMed ID: 38575912
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. prostate-Specific Antigen Screening in Smokers: A Comprehensive Analysis Using a National Behavioral Survey.
    Harmatz IM; Alkhatib KY; Leff M; Nolazco JI; Michel KF; Slinger M; McLauchlan N; Cortese BD; Roberson DS; Schurhamer B; Lee DJ; Malkowicz SB; Trinh QD; Bivalacqua TJ; Guzzo TJ; Pierorazio PM
    Urol Pract; 2024 May; 11(3):547-556. PubMed ID: 38564816
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Combination of prostate volume and apparent diffusion coefficient can stratify patients with a PI-RADS score of 3 to reduce unnecessary prostate biopsies.
    Dong Q; Wang C; Shen D; Ma Y; Zhang B; Xu S; Tao T; Xiao J
    Prostate; 2024 Jun; 84(8):780-787. PubMed ID: 38558415
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective.
    Yanada BA; Homewood D; Dias BH; Ogluszko C; Corcoran NM
    Urol Oncol; 2024 Jun; 42(6):175.e9-175.e18. PubMed ID: 38555235
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer.
    Dwina Y; Zaid LSM; Saraswati M; Rachmadi L; Kekalih A; Rahadiani N; Louisa M; Agustina H; Mochtar CA; Hamid ARAH
    Prostate; 2024 Jun; 84(8):738-746. PubMed ID: 38528654
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer.
    Habeshian TS; Cannavale KL; Slezak JM; Shu YH; Chien GW; Chen X; Shi F; Siegmund KD; Van Den Eeden SK; Huang J; Chao CR
    Epigenetics; 2024 Dec; 19(1):2308920. PubMed ID: 38525786
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
    Büttner T; Gärtner F; Essler M; Weiten R; Kristiansen G; Ellinger J; Ritter M; Krausewitz P
    Prostate; 2024 Jun; 84(8):772-779. PubMed ID: 38504659
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia Among Patients With Solid Tumors.
    Hufnagel DH; Bos LM; Brown AJ; Prescott LS
    J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38489926
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study.
    Lin TY; Chen IH; Weng HY; Lin YC; Ou CH; Li CY; Cheng YS
    World J Urol; 2024 Mar; 42(1):126. PubMed ID: 38460003
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Assessment of the Surgical Oncology Case Volume Within the Public Sector in Tanzania.
    Brand NR; Akoko L; Kotecha V; Mwakyembe T; Mwashambwa M; Hamid R; Hando D; Komba C; Mwanga A; Mbele P; Itule P; Jackson J; Misidai M; Gaskill C; Ozgediz D
    JCO Glob Oncol; 2024 Mar; 10():e2300316. PubMed ID: 38452305
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Performance of standard systematic biopsy versus MRI/TRUS fusion biopsy using the Navigo® system in contemporary cohort.
    Nativ O; Shefler A; Bejar J; Peschansky S; Lavi A; Michael C; Nativ O
    Urol Oncol; 2024 May; 42(5):159.e1-159.e7. PubMed ID: 38431487
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Sextant Systematic Biopsy Versus Extended 12-Core Systematic Biopsy in Combined Biopsy for prostate cancer.
    Chung JH; Song W; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Park BK
    J Korean Med Sci; 2024 Feb; 39(7):e63. PubMed ID: 38412610
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Partial gland ablation with high intensity focal ultrasound impact on genito-urinary function and quality of life: our initial experience.
    Fugaru I; Bouhadana D; Marcq G; Moryousef J; Rompré-Brodeur A; Meng A; Loutochin O; Loutochin G; Anidjar M; Bladou F; Sanchez-Salas R
    Can J Urol; 2024 Feb; 31(1):11784-11792. PubMed ID: 38401258
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 93.